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Abstract
Objective. The aim of this study is to report our experience using self-expandable covered metallic stents (Wallstent) to
treat different types of biliary strictures after orthotopic liver transplantation (OLT). Patients and methods. Between
January 1999 and July 2004, 222 OLTs were performed with choledocho-choledochostomy (CC) bile duct
reconstruction. An anastomotic biliary stricture was diagnosed and treated by endoscopic retrograde cholangiopan-
creatography (ERCP) or percutaneous procedures in 100 patients (45%). The group of 21 patients (mean age 57.09/
5.6 years) that were eventually treated with a biliary Wallstent was studied retrospectively. Results. Significant persistent
proximal or anastomotic strictures were diagnosed in 4 and 17 patients, respectively. A Wallstent was inserted by ERCP
or through a percutaneous route in 18 and 3 patients, respectively. The mean interval between diagnosis and Wallstent
insertion was 179.79/292.8 (01113) days. The mean total number of procedures required per patient was 7.49/5.5.
The mean stent primary patency duration was 10.89/7.8 (0.925.1) months with a 24-month primary patency rate of
26% at a mean follow-up time of 37.89/17.2 months. A hepatico-jejunostomy was performed in five patients (24%).
Two patients (10%) underwent retransplantation for diffuse ischemic cholangitis or chronic rejection. The overall
complication rate was 4%. Conclusion. Treatment of post-transplant biliary stenosis using a Wallstent is a valuable
option for delaying or avoiding surgery in up to 70% of patients. Proximal stenosis can be treated in the same manner
in selected patients with major comorbidities.
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Introduction
Bile duct anastomotic stricture is a common problem
after orthotopic liver transplantation (OLT) with a
reported incidence of 1520% [1]. The two usual
types of bile duct reconstruction performed at the
time of OLT are choledocho-choledochostomy (CC)
and hepatico-jejunostomy (HJ). Technical factors
such as duct size, size discrepancy, retransplantation
and diagnosis of liver disease such as sclerosing
cholangitis will influence the selection of CC versus
HJ. Biliary complications have always been a signifi-
cant cause of post-transplantation morbidity [2].
Endoscopic or trans-hepatic balloon dilatation and
stent insertion is a well recognized therapeutic option
for treatment of bile duct strictures [1]. However, the
use of self-expandable metallic stents to treat benign
conditions is not recommended.
The aim of this study was to report our experience
using Wallstents to treat different types of biliary
strictures occurring after OLT.
Patients and methods
Between January 1999 and July 2004, 306 cadaveric
OLT were performed in 279 patients at our institu-
tion. Among these, 222 (73%) had a CC and 84 had
an HJ. The HJ patients are excluded from the analysis.
Various postoperative biliary anomalies including
early postoperative inflammatory stenosis secondary
to edema, anastomotic stricture and ischemic cholan-
giopathy were diagnosed in 100 CC patients (45%).
This retrospective study reports all CC patients (n/
21) with intrahepatic, proximal or anastomotic ste-
nosis treated by Wallstent.
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Elevated liver function tests, angiocholitis or ab-
normal radiological findings such as dilatation of the
proximal bile duct or biloma prompted imaging of the
biliary tree by endoscopic retrograde cholangiopan-
creatography (ERCP). If a stricture was diagnosed,
endoscopic sphincterotomy, balloon dilatation and
plastic stent insertion was performed. Patients were
then rescheduled every 6 weeks for dilatation and
stent insertion until complete resolution of the stric-
ture. The same operator (A.R.) performed all the
endoscopic procedures. The percutaneous trans-he-
patic route was used only when the stricture could not
be canulated at the time of ERCP.
Self-expandable metallic stent (Wallstent) insertion
was selected for patients with: (i) a persisting stricture
despite a minimum of three adequate dilatations with
an 8 mm balloon; (ii) a stricture occurring more than
6 months post-OLT with obvious immediate absence
of response to dilatation. All patients were treated
with a self-expandable biliary metallic WallstentTM
endoprothesis with PermalumeTM covering and Uni-
stepTM plus delivery system from Boston Scientific
USA (the simple term Wallstent will be used through-
out the text).
Primary patency time was defined by the time
interval between Wallstent insertion and the first
episode of clinical obstruction requiring treatment.
Obstruction was defined by clinical jaundice or
angiocholitis and abnormal liver function tests show-
ing cholestasis. The obstruction was always confirmed
by ERCP or percutaneous trans-hepatic cholangio-
gram. Patients without symptoms and with normal
liver function tests were considered as having a patent
stent. Secondary patency time was defined by the
total duration of stent patency even though re-inter-
vention might have been required for removal of
biliary sludge but without requiring a new Wallstent
or plastic stent insertion.
Demographic and clinical data were collected using
systematic review of patients’ files and interrogation of
a computerized database. Statistics were calculated
using Statview version 5.0 for MacIntosh.
Results
Ten men and 11 women with a mean age of 579/5.6
years (mean9/SD) were studied. The patients’ char-
acteristics are summarized in Table I. Indications for
transplantation included alcoholic cirrhosis (three
patients), chronic hepatitis B (one patient) or C (three
patients), primary biliary cirrhosis (two patients),
non-alcoholic steato-hepatitis (two patients), a1-anti-
trypsin deficiency (one patient), giant cell hepatitis
(one patient), cryptogenic cirrhosis (five patients),
idiopathic fulminant hepatic failure (one patient) and
hepatocellular carcinoma (two patients).
The operative time and cold and warm ischemic
times for the 21 studied cases were 2259/60, 4609/
158 and 409/9 min, respectively. Blood losses were
14209/1100 ml (range 4003500). Donor age was
45.59/16.2 years (range 1770).
Proximal and anastomotic stenosis was diagnosed
in 4 and 17 patients, respectively. A Wallstent was
inserted by ERCP in 18 patients and by percutaneous
approach in 3 patients. A concomitant bile leak was
identified in four patients (19%) (Figure 1).
The mean interval between diagnosis and Wallstent
insertion was 179.79/292.8 (01113) days. The total
number of procedures required per patient was 7.49/
5.5, with 3.79/3.9 procedures performed before
and 2.79/3.4 after Wallstent insertion. Globally,
1.89/1 Wallstents were inserted per patient with
nine patients needing a second Wallstent. Eight
patients required endoscopic cleaning of biliary sludge
inside the Wallstent during the course of the follow-
up. Seven patients eventually underwent plastic stent
insertion for inadequate drainage by Wallstent only
during follow-up.
The mean primary patency duration of the Walls-
tent was 10.89/7.8 (0.925.1) months. After a mean
follow-up time of 37.89/17.2 months, the 12-,
18-, and 24-month primary patency rates were
64%, 51%, and 26%, respectively (Figure 2). The
yearly secondary patency rates from 1 to 5 years
were: 95%, 95%, 88%, 66%, and 35%, respectively
(Figure 3).
Fourteen patients (66%) were treated solely by
Wallstent without recurrence of problem. An HJ was
performed in five (24%) patients because of recurrent
obstruction of the Wallstent, in the context of a good
Table I. Patients’ characteristics.
Parameter Value
Weight (kg) 72.29/12.7
Height (cm) 1669/7
Body mass index (BMI) 26.39/4.3
Child Pugh score (BC) 119/1.5 (912)
MELD 19.69/10.5
Donor age (year) (minmax) 45.59/16.2 (1770)
Donor CMV /// 13/8
Figure 1. Evolution for patients with Wallstent. OLT, orthotopic
liver transplantation; CC, choledocho-choledochostomy; HJ, hepa-
tico-jejunostomy.
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general condition and complete recovery from the
OLT. Two patients (10%) underwent retransplanta-
tion for diffuse ischemic cholangitis (n/1) and
chronic rejection (n/1) after a mean interval of
782.19/638.2 days after diagnosis. No graft was
lost secondary to the use of a Wallstent. A total
of 156 procedures were realized in our studied
population. Six complications (4%) of those 156
procedures were encountered in 6 patients: 3 pan-
creatitis, 2 cholangitis, and 1 case of aeroportia. All
those complications were medically treated with a
rapid recovery and a favorable outcome without
prolongation of hospital stay.
When an HJ bile reconstruction was required in the
course of the follow-up, no technical difficulty was
encountered at the time of surgery for removal of the
Wallstent. All the patients had a patent bile duct once
the Wallstent was removed. The HJ bile reconstruc-
tions were easily performed without postoperative
anastomotic leak or anastomotic stricture in the
course of the follow-up.
Discussion
Biliary Wallstents were proven to be superior to plastic
stents in the context of malignant biliary obstruction
because of increased patency duration. However, in
the setting of benign disease, such as bile duct
stricture post liver transplantation, the use of
Wallstents has been associated with poor results and
is not recommended [3].
Bile duct complications are a common event after
liver transplantation, with a reported incidence of
1520% [1,4]. Postoperative bile duct anastomotic
strictures are a frequent cause of postoperative allo-
graft dysfunction. Sutcliffe et al. showed that 49% of
patients who had a demonstrable bile duct obstruc-
tion also had histological evidence of nonbiliary
pathology [5]. Multiple factors are involved in the
physiopathology of the strictures including technical
factors at the time of surgery, bile duct size, prolonged
cold ischemia time, previous portocaval shunt, vas-
cular compromise, acute or chronic rejection, CMV
infection, ABO incompatibility, and recurrent disease
such as sclerosing cholangitis. However, the nonsur-
gical causes are more frequently associated with
multiple intrahepatic strictures [1,6].
ERCP is the first-line modality for bile duct
imaging after a CC. When treatment is required, a
survey of practices in the USA found that therapeutic
ERCP, percutaneous and surgical approaches were
selected as the initial therapeutic modality in 45%,
22%, and 29% of cases, respectively [7]. Those
approaches were successful in 2791% of the cases
[8]. Therapeutic ERCP will allow balloon dilatation
of the stricture with or without stent insertion. Stent
insertion gives a better success rate than dilatation
alone [8,9]. However, the stent must be changed
regularly, with an average lifespan of 34 months
[9,10].
Patients presenting with a persistent stenosis des-
pite adequate balloon dilatation and stenting will be
best served by surgical revision and reconstruction
using an HJ. Low bile duct stricture recurrence rate
and a 4-year success rate of 88% has been obtained
post HJ [11]. Nonetheless, reconstruction can be
difficult in patients with multiple comorbidities or
previous abdominal surgery, with a higher recurrence
rate [12]. Timing of reconstructive bile duct surgery
will also be of essence in the context of a patient
recovering from a liver transplantation with all the
inherent complications of the initial surgery and the
potential morbidity of the upcoming reconstructive
surgery.
In our population of transplanted patients, we
favor ERCP as a primary mode of evaluation and
treatment of all postoperative patients harboring
cholestasis. If ERCP fails, diagnosis will be made by
percutaneous trans-hepatic cholangiogram. Treat-
ment will be selected based on assessment of the
global clinical situation. An HJ will be selected only
for the good candidates. Patients with a worse out-
come post OLT or presenting with major comorbid-
ities will be considered for Wallstent insertion with a
global success rate of bile duct salvage of 70%.
Despite good initial results with Wallstents, a primary
Figure 2. Primary patency rate of the Wallstent.
Figure 3. Secondary patency rate of the Wallstent.
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patency rate of 26% at 24 months was obtained.
Secondary patency rate can be improved by ERCP
revision of the Wallstent, insertion of a plastic stent or
use of a second Wallstent [3]. However, this approach
is plagued by increased cost, repeated ERCP with
consequent patient discomfort and potential morbid-
ity of the procedures. In our experience, Wallstents
were not associated with any complications beside
obstruction. No patient needed a second transplanta-
tion because of complications related to Wallstent
insertion. ERCP and Wallstent insertion did not
impact in any way on the reconstructive surgery.
The Wallstents were easily removed since they were
covered stents and probably also because of the woven
conception. Furthermore, Wallstent insertion did
not cause any change in the bile duct epithelium
seen at pathology analysis. No stenosis of the HJ was
encountered at follow-up and all the patients have
liver function tests.
Recently, we partially changed our approach, using
what we named ‘temporary’ Wallstent. We have
treated four patients with short anastomotic strictures
by Wallstent insertion with the intention of eventual
removal. We used 8 cm long covered stents that were
purposely positioned to leave a length of 11.5 cm
protruding into the lumen of the duodenum. Those
stents were removed 6 months later with excellent
results. This modality is still under study.
Conclusions
Post liver transplantation bile duct anastomotic stric-
tures can be treated successfully by therapeutic ERCP
with balloon dilatation and stent insertion. In a
situation of persistent stenosis, a reconstructive sur-
gery by HJ is the standard treatment. Wallstent
insertion is a valuable alternative. It allows the
clinician to avoid or delay a reconstructive procedure
in up to 70% of the patients. Endoscopic revision of
the stent is simple with a low complication rate.
Proximal stenosis may also be treated by Wallstent
insertion in selected patients with major comorbid-
ities. No technical problem was encountered during
the removal of the stent at the time of surgery when
HJ was needed. The use of a temporary Wallstent
to dilate a post-transplant stenosis is presently
under study.
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